Castle Biosciences, Inc.
Castle Biosciences, Inc. scores highest on Nitro (74) and lowest on Price (28). Its PosiPenta is 50.28 out of 100, around the middle of similar companies.
On the Penta Grid this week, Castle Biosciences, Inc. is Grid #280 of 836 in the Healthcare sector in United States, and Grid #1,842 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Castle Biosciences, Inc. | 50.28 | 28 | 35 | 74 | 64 | 51 |
| Janux Therapeutics, Inc. | 42.13 | 38 | 24 | 45 | 69 | 34 |
| Bioventus Inc. | 62.70 | 51 | 58 | 86 | 56 | 63 |
| Latigo Biotherapeutics, Inc. | 26.19 | 0 | 30 | 40 | 8 | 53 |
| MannKind Corporation | 54.25 | 0 | 81 | 45 | 99 | 46 |
| Beta Bionics, Inc. | 40.81 | 19 | 26 | 53 | 64 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -49.94 |
| P/B ratio | 2.08 |
EEarnings
| Trailing EPS | ₹-60.62 |
| Forward EPS | ₹-86.51 |
NNitro
| Price | 3027.09 |
| 52-week high | 4193.98 |
| 52-week low | 1678.54 |
| Fall from 52-week high | 27.8% |
TTorque
| Return on equity (ROE) | -4.20% |
| Debt-to-equity | 0.08 |
AAnchor
| Beta (price swings) | 0.94 |
| Market cap | ₹9,247 Cr |
| Insider holding | 2.38% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Castle Biosciences, Inc.'s PosiPenta score?
Castle Biosciences, Inc.'s PosiPenta is 50.28 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Castle Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Castle Biosciences, Inc. is Grid #280 of 836 in the Healthcare sector in United States, and Grid #1,842 of 3,999 in United States.
Which PosiPenta pillar is strongest for Castle Biosciences, Inc.?
Nitro (momentum), with a score of 74 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Castle Biosciences, Inc.?
Price (valuation), with a score of 28 out of 100: weaker than most similar companies.
Has Castle Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.63 points, from 48.65 to 50.28.
PositoAI is for research and education only and is not investment advice.